Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

DIAZEPAM

DIAZEPAM

Standard Dose
5MG/ML (5MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview DIAZEPAM is listed in Drugs@FDA under application 070311 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient DIAZEPAM Form and strength INJECTABLE;INJECTION - 5MG/ML (5MG/ML) Sponsor HIKMA Submission history Latest submission status date: 2024-12-16 00:00:00.

Structured Monograph

Clinical summary

Approval overview DIAZEPAM is listed in Drugs@FDA under application 070311 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient DIAZEPAM Form and strength INJECTABLE;INJECTION - 5MG/ML (5MG/ML) Sponsor HIKMA Submission history Latest submission status date: 2024-12-16 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.